Literature DB >> 7161362

Reversed-phase liquid chromatographic investigation of UV-absorbing low-molecular-weight compounds in saliva.

K Nakano, S P Assenza, P R Brown.   

Abstract

The reversed-phase mode of high-performance liquid chromatography was used to determine the intra- and inter-individual levels of UV-absorbing low-molecular-weight compounds in saliva. Many of the compounds known to occur in serum were also found in saliva; however, concentrations in saliva are lower. Both the intra- and inter-individual levels of these compounds vary significantly; in most cases, the inter-individual variance is 2-3 times the intra-individual variance. Caffeine and its metabolites in saliva are also reported. A greater number of metabolites were found in the saliva of habitual coffee drinkers. After caffeine was administered orally, paraxanthine, theobromine, theophylline, 1-methylxanthine, and 1-methyluric acid were found in the saliva of an individual who did not drink coffee regularly. In this subject, the serum half-life for caffeine was 3.49 h and the saliva half-life was 3.27 h. The half-life of caffeine in an habitual coffee drinker who had refrained from caffeine products for four days was 4.39 h.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7161362     DOI: 10.1016/s0378-4347(00)81730-2

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Rapid and sensitive gas-chromatographic determination of caffeine in blood plasma, saliva, and xanthine beverages.

Authors:  H W Teeuwen; E L Elbers; J M van Rossum
Journal:  Mol Biol Rep       Date:  1991-02       Impact factor: 2.316

2.  Identification of suppressive components in "Haemophilus somnus" fractions which inhibit bovine polymorphonuclear leukocyte function.

Authors:  Y W Chiang; M L Kaeberle; J A Roth
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

3.  Caffeine-Containing, Adaptogenic-Rich Drink Modulates the Effects of Caffeine on Mental Performance and Cognitive Parameters: A Double-Blinded, Placebo-Controlled, Randomized Trial.

Authors:  Ali Boolani; Daniel T Fuller; Sumona Mondal; Tyler Wilkinson; Costel C Darie; Eric Gumpricht
Journal:  Nutrients       Date:  2020-06-29       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.